Heparin 5000 IU/5mL injection 50 pack ampoules
Published 13 August 2017
Product
Single batch: Batch A473 Expiry date Feb 2019 ARTG Number AUST R 49232
Why it was recalled
Potential for incorrect product in package. The recall for product correction was initiated after one NSW consumer being treated with Heparin 5000 IU/5 mL injection 50 pack ampoules, found the pack contained ampoules of a different Pfizer product, Lignocaine 50 mg/5 mL (Batch A313, expiry date Nov 2017). The consumer obtained the pack at a community pharmacy in NSW. Consumers and health professionals who identify a defective pack should follow the advice below.
Hazard
Heparin is used as a "blood-thinner" in people susceptible to blood-clotting and Lignocaine is an anaesthetic. If a patient has an affected pack, there is a risk that they will not have adequate supply of their medicine and could take the incorrect medicine, which could have serious health consequences.
Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.